Edition:
India

Moleculin Announces Confirmatory In Vitro Analysis Of WP1122


Tuesday, 16 Jun 2020 

June 16 (Reuters) - Moleculin Biotech Inc ::MOLECULIN ANNOUNCES CONFIRMATORY IN VITRO ANALYSIS OF WP1122.MOLECULIN BIOTECH INC - ANNOUNCED THAT A REPEAT OF PREVIOUS IN VITRO TESTING HAS CORROBORATED ANTIVIRAL POTENTIAL OF WP1122.MOLECULIN BIOTECH - RESULTS OF REPEATED ROUND OF IN VITRO TESTING RECEIVED, CONFIRM WP1122 HAS AN ANTIVIRAL EFFECT ON HUMAN CORONAVIRUS 229E.MOLECULIN BIOTECH - EXPECTS TO FILE REQUEST FOR IND STATUS TO TEST WP1122 FOR TREATMENT OF COVID-19 PATIENTS DURING H2 2020.